Loading clinical trials...
Loading clinical trials...
Phase III Randomized Study of R-CHOP V. Dose-Adjusted EPOCH-R With Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas
Conditions
Interventions
rituximab
cyclophosphamide
+6 more
Locations
47
United States
Rebecca and John Moores UCSD Cancer Center
La Jolla, California, United States
Camino Medical Group - Treatment Center
Mountain View, California, United States
Palo Alto Medical Foundation
Palo Alto, California, United States
Naval Medical Center - San Diego
San Diego, California, United States
Saint Helena Hospital
St. Helena, California, United States
Eastern Connecticut Hematology and Oncology Associates
Norwich, Connecticut, United States
Start Date
May 1, 2005
Primary Completion Date
October 1, 2017
Completion Date
November 15, 2021
Last Updated
November 17, 2021
NCT07260812
NCT05006716
NCT06026319
NCT07368270
NCT07255963
NCT05940272
Lead Sponsor
Alliance for Clinical Trials in Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions